British Equine Veterinary Association > Archive > News & Views
We have updated our Privacy Policy. You can find out more here.
BEVA Logo

News and Views

This area allows you to:

  • View latest news items and search for older stories by keywords or category.
  • Keep up to date with BEVA Blog, maybe even contributing yourself. Email us for more information

Search News

News Archive


BHA Comment on Dexamethasone Use

Following the positive result of a precautionary test on the Cheltenham bound Binocular the BHA’s Tim Morris has reassured BEVA that there has been no change in testing sensitivities.  He is not advising vets to change the standard c7day withdrawal period “where a single IV injection of Dexamethasone Sodium Phosphate is administered at the standard dose rate”.   Prof. Morris states “We are rigorous in how we change lab levels, it's a formal process with a long lead in time when we inform vets. For example next Monday the board will be asked to approve Detection Times for clenbuterol and Ipratropium, which we have to do before any change, and we then we must do an education campaign and lead-in for several months.”   Prof. Morris has acknowledged that the lack of Detection Times for steroids is an issue.  He has commented that the previous HKJC advised detection periods / the old Jockey Club “red book” should not be relied upon – and has pointed those treating racehorses towards The European Horserace Scienti ...

African Horse Sickness (AHS) outbreaks in South Africa

South Africa has reported three outbreaks of African Horse Sickness (AHS) in free roaming horses in Mamre area of Western Cape Province within the AHS control zone surveillance area. The serotype has been identified as serotype 1. The three affected animals were all found dead since February 26th and subsequent post mortem confirmed disease using PCR. Disease control measures are in place and vaccination will be used.

Merial and Intervet/Schering-Plough Deal Off

Merck and sanofi-aventis announced today the mutual termination of their agreement to form a new animal health joint venture by combining Merial, the animal health business of sanofi-aventis, with Intervet/Schering-Plough, Merck's animal health unit. As a result, each party will keep its current, separate animal health assets and businesses. Since the initial announcement about the intended combination on March 9, 2010, both companies have worked diligently to create the proposed animal health joint venture, including submitting requests for the required antitrust reviews. The companies are discontinuing their agreement primarily because of the increasing complexity of implementing the proposed transaction, both in terms of the nature and extent of the anticipated divestitures and the length of time necessary for the worldwide regulatory review process. Merck and sanofi-aventis mutually determined that ending their plan is in the best interests of both companies and their respective shareholders, as well as t ...

Book your stand at Congress 2011 NOW!

Book your trade stand at Liverpool now!!!

Are you an experienced team Vet?

A fantastic opportunity for an experienced team vet!

Queens Award for Equestrianism

John Killingbeck is nominated for the Queen's Award for Equestrianism

New Online Access to the HBLB Codes of Practice

HBLB Press Release for new online access to the HBLB Codes of Practice

2011 BEVA Shipped Semen Certification

2011 BEVA Shipped Semen Certificate

Sad News

It is with great sadness that BEVA is announcing the death of SAEVA's Past President Dr Dave Mullins. Our condolences go to his family, friends and colleagues.

Equine Viral Arteritis (EVA) confirmed in West Sussex

Disease Notification

SunBlog_Meta

SunBlog_Search

SunBlog_Archive